Viscart 48 mg (2%) 2,4 ml –Intra-Articular Injection
Warning: The content of this page is prepared only for healthcare professionals. If you are not a healthcare professional, consult a physician and/or pharmacist for more information.
Viscart 48 mg (2%) 2,4 ml –Intra-Articular Injection
Viscart 2% viscoelastic sodium hyaluronate solution for intraarticular injection
The package contains 2.4ml of viscoelastic solution in a disposable glass syringe suitable for intraarticular use.
Description:
Viscart 2% is a highly purified, high molecular weight sodium hyaluronate solution in a sterile, apirogenous, clear, non-inflammatory, physiological saline solution.
High purity sodium hyaluronate is obtained from bacteria by fermentation.
Viscart 2% is a product used to relieve stiffness and pain in patients' knees and other synovial joints with degenerative and traumatic changes. Viscart 2% contains 20 mg sodium hyaluronate, sodium chloride, disodium hydrogen phosphate, sodium hydrogen phosphate, sodium dihydrogen phosphate and water for injection.
Viscart 2% has a PH value of 6.8-7.6 and an omission of 300-350 mOsm/kg, similar to synovial fluid.
Features and Effectiveness:
All synovial joints, especially weight-bearing joints, contain viscoelastic sodium hyaluronate. This substance has sliding and shock-absorbing properties, which ensures normal and painless movement of the joints. In patients with degenerative joints (osteoarthritis), the viscoelasticity of the synovial fluid is greatly impaired, which leads to increased pressure on the joint and deterioration of the articular cartilage, thus limiting joint movements and pain. Intraarticular administration of high-purity sodium hyaluronate, which has very good viscoelastic properties, can improve the quality of joint lubrication. The product's sliding and shock-absorbing properties reduce pain and improve joint mobility. This effect may persist for several months following the recommended treatment cycle.
Indications:
Viscart 2% is a non-pharmacological treatment and is resistant to simple analgesics (eg. Acetaminophen (paracetamol)) is indicated in knee pain in patients with osteoarthritis (OA) who are unable to respond adequately.